Pazopanib Maintenance Therapy Delays Relapse in Advanced Ovarian Cancer
Maintenance therapy with pazopanib after successful initial chemotherapy for advanced ovarian cancer prolongs time to relapse and PFS compared to placebo, found research presented at ASCO 2013.